CG Oncology (CGON) EPS (Basic) (2023 - 2026)
CG Oncology's (CGON) quarterly EPS (Basic) came in at -$5.24 in Q1 2026, down 227.94% YoY from $4.1 in Q1 2025, and down 888.81% on a QoQ basis from -$0.53 in Q4 2025.
CG Oncology (CGON) EPS (Basic) (2023 - 2026) Analysis & Trends
CG Oncology (CGON) has 4 years of EPS (Basic) data on file, last reported at -$5.24 in Q1 2026.
- Quarterly EPS (Basic) fell 227.94% year-over-year to -$5.24 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$10.25 (down 305.01% YoY) and the FY2025 annual result came in at -$2.08, down 47.84% from the prior year.
- EPS (Basic) retreated to -$5.24 in Q1 2026, from -$0.53 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.28 in Q2 2024 to a low of -$5.24 in Q1 2026.
- A 4-year average of -$2.32 and a median of -$1.94 in 2025 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2024 — EPS (Basic) jumped 92.78% — and 2025, when it sank 905.37%.
- Tracing CGON's EPS (Basic) over 4 years: stood at -$5.19 in 2023, then jumped by 90.2% to -$0.51 in 2024, then slipped by 4.18% to -$0.53 in 2025, then tumbled by 888.81% to -$5.24 in 2026.
- The last three EPS (Basic) figures came in at -$5.24 (Q1 2026), -$0.53 (Q4 2025), and -$3.06 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | CG Oncology | 6.63 Bn | 6.63 Bn | -2.77 Mn | -5.28 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -5.28 |
| Mar 31, 2026 | -5.24 |
| Dec 31, 2025 | -0.53 |
| Sep 30, 2025 | -3.06 |
| Jun 30, 2025 | -1.94 |
| Mar 31, 2025 | -1.60 |
| Dec 31, 2024 | -0.51 |
| Sep 30, 2024 | -0.30 |
| Jun 30, 2024 | -0.28 |
| Mar 31, 2024 | -0.36 |
| Dec 31, 2023 | -5.19 |
| Sep 30, 2023 | -4.00 |
| Jun 30, 2023 | -3.93 |
| Mar 31, 2023 | -3.22 |